Lucas SJ, Lewis NC, Sikken EL, Thomas KN, Ainslie PN. Slow breathing as a means to improve orthostatic tolerance: a randomized sham-controlled trial. J Appl Physiol 115: 202-211, 2013. First published May 16, 2013 doi:10.1152/japplphysiol.00128.2013.-Endogenous oscillations in blood pressure (BP) and cerebral blood flow have been associated with improved orthostatic tolerance. Although slow breathing induces such responses, it has not been tested as a therapeutic strategy to improve orthostatic tolerance. With the use of a randomized, crossover sham-controlled design, we tested the hypothesis that breathing at six breaths/min (vs. spontaneous breathing) would improve orthostatic tolerance via inducing oscillations in mean arterial BP (MAP) and cerebral blood flow. Sixteen healthy participants (aged 25 Ϯ 4 yr; mean Ϯ SD) had continuous beat-to-beat measurements of middle cerebral artery blood velocity (MCAv), BP (finometer), heart rate (ECG), and end-tidal carbon dioxide partial pressure during an incremental orthostatic stress test to presyncope by combining head-up tilt with incremental lower-body negative pressure. Tolerance time to presyncope was improved (ϩ15%) with slow breathing compared with spontaneous breathing (29.2 Ϯ 5.4 vs. 33.7 Ϯ 6.0 min; P Ͻ 0.01). The improved tolerance was reflected in elevations in low-frequency (LF; 0.07-0.2 Hz) oscillations of MAP and mean MCAv, improved metrics of dynamic cerebrovascular control (increased LF phase and reduced LF gain), and a reduced rate of decline for MCAv (Ϫ0.60 Ϯ 0.27 vs. Ϫ0.99 Ϯ 0.51 cm·s Ϫ1 ·min Ϫ1 ; P Ͻ 0.01) and MAP (Ϫ0.50 Ϯ 0.37 vs. Ϫ1.03 Ϯ 0.80 mmHg/min; P ϭ 0.01 vs. spontaneous breathing) across time from baseline to presyncope. Our findings show that orthostatic tolerance can be improved within healthy individuals with a simple, nonpharmacological breathing strategy. The mechanisms underlying this improvement are likely mediated via the generation of negative intrathoracic pressure during slow and deep breathing and the related beneficial impact on cerebrovascular and autonomic function. orthostatic tolerance; cerebral blood flow oscillations; controlled breathing SYNCOPE IS A TRANSIENT LOSS of consciousness resulting from an insufficient supply of oxygen to the brain (15). Regardless of the pathogenesis of syncope, which is still to be fully elucidated, the loss of consciousness is ultimately due to a critical reduction in blood flow to the brain stem (48). The importance of respiratory influences on cerebral blood flow and presyncope has been highlighted (5, 23, 31, 36) , with the development of hyperventilationinduced hypocapnia at presyncope that acts to reduce cerebral blood flow (48), facilitating the onset of syncope.
SYNCOPE IS A TRANSIENT LOSS of consciousness resulting from an insufficient supply of oxygen to the brain (15) . Regardless of the pathogenesis of syncope, which is still to be fully elucidated, the loss of consciousness is ultimately due to a critical reduction in blood flow to the brain stem (48) . The importance of respiratory influences on cerebral blood flow and presyncope has been highlighted (5, 23, 31, 36) , with the development of hyperventilationinduced hypocapnia at presyncope that acts to reduce cerebral blood flow (48) , facilitating the onset of syncope.
The respiratory influence on exacerbating syncope raises a critical question of whether regularization of breathing could be used as an effective means to improve orthostatic tolerance. In addition to maintaining arterial blood gases (and therefore, limiting the extent of hypocapnic-induced cerebral hypoperfusion), slow and deep breathing may reduce sympathetic activity by enhancing central inhibitory rhythms (34) and conversely, may lead to a baroreflex efficiency (3) , although this is not a universal observation (9, 29) . Such factors have been associated with greater respiratory sinus arrhythmia and blood pressure (BP) oscillations (35) . For example, negative intrathoracic pressures are known to improve right venous return and left ventricular stroke volume (SV) (4, 17) ; therefore, if peripheral vascular resistance remains unchanged, any given increase in left ventricular output would cause a proportional rise in mean arterial BP (MAP) and therefore, likely contribute to the increase in cerebral blood flow. Furthermore, the importance of intrathoracic pressures and the "respiratory pump" in assisting venous return and therefore, cardiac output (Q ) to improve orthostatic tolerance has been reported indirectly from a series of studies where participants breathed with inspiratory resistance (6, 40, 43) . Consistent with their findings, with the use of a device to increase inspiratory resistance, higher endogenous oscillations in BP and cerebral perfusion were associated with improved tolerance to orthostatic stress (39) .
To date, however, no study has investigated whether changes in simply breathing rate alone can improve orthostatic tolerance within an individual. This is conceivable, since it would appear that slow, deep breathing induces oscillations in BP and thus cerebral blood flow, potentially improving tolerance to orthostatic stress. Therefore, we examined the hypothesis that slow, deep breathing would improve orthostatic tolerance via inducing oscillations in BP and cerebral blood flow and stabilizing carbon dioxide partial pressure (PCO 2 ) during the orthostatic stress. To address this hypothesis, while using a randomized, crossover sham-controlled study design, we monitored cardiorespiratory and cerebrovascular responses continuously during an incremental orthostatic stress test to presyncope.
METHODS

Participants.
Sixteen healthy volunteers (10 men and six women; aged 25 Ϯ 4 yr; body mass index 23 Ϯ 2 kg/m 2 ) participated in this study after providing written, informed consent. The study was approved by the Human Ethics Committee of the University of Otago and conformed to the standards set by the Declaration of Helsinki. All participants were nonsmokers; had no previous history of cardiovascular, cerebrovascular, or respiratory diseases; and were not taking any medication. A majority of the participants were recreationally active, typically engaging in low (e.g., walking)-and moderate (e.g., jogging)-intensity aerobic activities (3-5 days/wk), and none was a competitive athlete. None of the participants reported episodes of syncope and/or related symptoms in his or her normal daily lives. Female participants were tested in the early follicular phase (days 1-7) of the menstrual cycle, determined by the 1st day of menstruation, or during menstruation of the pill-withdrawal phase (approximately days 2-7).
Experimental design. Participants attended the laboratory on three occasions. The first visit was for familiarization with the experimental protocols and equipment. On the second and third visits, data were collected in response to an orthostatic tolerance test, while participants either breathed at a controlled rate (at six breaths/min) or were allowed to breathe spontaneously throughout the protocol. All visits to the laboratory were separated by at least 24 h; the breathing protocol for the first experimental trial was randomized among participants, and the two experimental trials were conducted at the same time of day for each participant. The room temperature was maintained at 20 -23°C. All trials began after a 12-h abstinence from caffeine, a 24-h abstinence from alcohol and strenuous exercise, and at least a 4-h fast. On arrival to the laboratory for data collection, participants voided their bladder and provided a urine sample. Hydration status was assessed by measuring urine-specific gravity with a handheld clinical refractometer (Atago hand refractometer; AstraZeneca, Osaka, Japan) and did not differ between experimental trials (1.021 Ϯ 0.008 vs. 1.023 Ϯ 0.007; P ϭ 0.21).
Breathing protocol. In the controlled breathing trial, participants wore headphones and listened to a looped-repeated recording of breathing at six breaths/min (5 s inspiration and 5 s expiration). Participants were asked to match the rate throughout the trial; this was confirmed via monitoring of tidal volume, respiratory frequency, and subsequent spectral analysis. For the spontaneous trial, participants were instructed to breathe normally and not "control" their breathing during the orthostatic challenge.
For both trials, participants were given a "tonic" (50 ml) that was described as "an ergogenic aid to improve orthostatic tolerance." Participants were told that for one of the two trials, this tonic contained the ergogenic aid, whereas the other was a placebo. In reality, both tonics were distilled water, which was not disclosed to them until the study was completed (for all participants). The objective of this tonic was to remove perceived focus from the breathing strategy as the means of improving orthostatic tolerance, therefore creating our sham study design. Importantly, previous research has established that 50 ml of water ingestion does not alter orthostatic tolerance (46) .
Head-up tilt and lower-body negative pressure test. Following instrumentation, participants were placed on the combined tilt/lower-body negative pressure (LBNP) table and rested supine for at least 15 min. Participants were then tilted to 60°for 15 min, where they remained until termination of the subsequent LBNP protocol. Lower-body suction was applied in Ϫ10-mmHg incremental steps for 5 min each (24, 50) . The test was terminated on the participant's request due to subjective symptoms of presyncope (feelings of dizziness, nausea, faintness, visual disturbances, hearing disturbances, and fatigue) or when a continuous drop in systolic BP (SBP) Ͻ80 mmHg for more than 10 s was observed. Participants were then returned immediately to the supine position for 3 min before measurements ceased. Although previous researchers have used the Ͻ80 mmHg as the SBP cutoff point (24) , data from our laboratory indicate that respiratoryinduced swings in BP occur (and were proactively induced in the current protocol), especially at lower SBP between 75 and 85 mmHg (50) . This less-conservative criterion of termination of the syncope protocol allowed better monitoring of physiological changes immediately before syncope.
Orthostatic tolerance. Orthostatic tolerance was assessed using two complementary measures: 1) time to presyncope and 2) a cumulative stress index (25, 26, 28) , which was calculated for each participant as the sum of the product of the duration of LBNP and the magnitude of the pressure at each level (mmHg ϫ min).
Presyncopal symptoms. Presyncopal symptoms were recorded using a validated questionnaire, as described previously (50) . Immediately following the tilt-LBNP maneuver, participants were asked to rate their symptoms evident at their "presyncope" end-point.
Physiological measurements. Blood flow velocity in the middle cerebral artery (MCAv), BP, end-tidal PCO 2 (PETCO2), and heart rate (HR) was recorded continuously. Beat-to-beat blood flow velocity in the right MCA was measured using a 2-MHz-pulsed Doppler ultrasound system (DWL Doppler; Compumedics, Singen, Germany). With the use of search methods described elsewhere (1, 55) , the Doppler probe was maintained in position, at a fixed angle, using a fixation headframe (Marc 600; Spencer Technologies, Seattle, WA). Beat-to-beat BP was measured by finger photoplethysmography (Finometer; Finapres Medical Systems, Amsterdam, The Netherlands), and HR was recorded via a three-lead electrocardiography (ECG). In addition, following 5-10 min of supine rest and during the 15-min head-up tilt (HUT), manual sphygmomanometer BP recordings were obtained to confirm the accuracy of the finger photoplethysmography measurements; if the BP at baseline differed markedly between the manual and finger photoplethysmography, then the finometer cuff was replaced (or if needed, the hand was warmed) until adequate agreement between the two methods was apparent. Our previous studies have confirmed the accuracy of finger photoplethysmography as a reliable index of intra-arterial pressure at presyncope (50) .
SV and Q were calculated from the BP waveform obtained from the finger photoplethysmography using the Modelflow method, incorporating age, sex, height, and weight (BeatScope 1.0 software; TNO TPD Biomedical Instrumentation, Amsterdam, The Netherlands). Total peripheral resistance index (TPRi) was calculated from MAP/Q . Cerebrovascular resistance index (CVRi) was calculated as mean MAP/mean MCAv.
PETCO2 was sampled from a leak-free facemask attached to a Y-shaped, two-way nonrebreathing valve (Hans Rudolph 7900 series; Hans Rudolph, Shawnee, KS) and measured by a fast-responding gas analyzer (model CD-3A; AEI Technologies, Pittsburgh, PA). Tidal volume and frequency were measured using a heated pneumotach (Hans Rudolph 3813; Hans Rudolph), and ventilation was calculated from the spirometry flow waveform.
Assessment of dynamic cerebrovascular control and baroreflex sensitivity using transfer function analysis. Beat-to-beat MAP and mean MCAv signals recorded during HUT baseline and for the last-tolerated 5-min stage of LBNP were cubic-spline interpolated and resampled at 4 Hz for spectral and transfer function analysis (TFA), based on the Welch algorithm. Each 5-min recording was first subdivided into five successive windows that overlapped by 50%. The data within each window were detrended linearly, passed through a Hanning window, and subjected to fast Fourier transform analysis. For TFA, the cross-spectrum between MAP and mean MCAv was determined and divided by the MAP autospectrum to derive the transfer function gain, phase, and coherence indices. Spontaneous MAP and mean MCAv spectral powers and the mean value of transfer function coherence, gain, and phase were calculated in the very low (0.02-0.07 Hz)-and low (0.07-0.20 Hz)-frequency (VLF and LF, respectively) ranges, where dynamic cerebrovascular control is thought to operate (53) . To ensure that robust phase and gain estimates within the VLF and LF bands were entered for subsequent analysis, we averaged only those gain and phase values where the corresponding coherence was Ն0.5, indicative of at least 50% shared variance. In the context of applications of this technique, the absence of dynamic cerebrovascular control would manifest as increases in coherence and gain (13, 58) and reductions in phase (38) . Conversely, an enhanced dynamic cerebrovascular response would theoretically be associated with reductions in coherence and gain and increases in phase. Similarly, spontaneous cardiac-vagal baroreflex sensitivity (BRS) was derived from the spectral powers analysis of the R-R and SBP intervals, as well as from the transfer function gain, phase, and coherence indices at 0.1 Hz for the controlled breathing (56) and across the frequency ranges during spontaneous breathing. With this approach of cardiac baroreflex estimation, transfer gain quantifies the magnitude of the relation between changes in SBP and R-R interval; a higher gain indicates higher BRS, because there is more R-R interval change for a given SBP change. The phase function shows the temporal displacement of the R-R interval to SBP, quantifying how SBP leads the R-R interval, with a less-negative phase indicating faster changes in the R-R interval in response to SBP. Coherence function quantifies the extent to which changes in the R-R interval are linearly correlated with changes in SBP. All data were sampled continuously at 200 Hz using an analog-digital converter (PowerLab/16SP ML795; ADInstruments, Dunedin, New Zealand) interfaced with a computer and displayed in real time during testing. Data were stored for subsequent offline analysis using the commercially available LabChart software (v7.3; ADInstruments).
Since we set the breathing frequency at 0.1 Hz for the controlled breathing protocol, we report the spectral powers and TFA measures at that frequency and compared them with the values obtained within each frequency band during spontaneous breathing (including high frequency, 0.20 -0.40 Hz). We also did this for the cardiac-baroreflex metrics, because the increased coherence between induced changes in SBP and R-R interval made the linear TFA feasible under these conditions. Although subtle differences in frequency bands are often used for spontaneous measures, if we use slightly different banding definitions for TFA, findings remain unaltered (52) . Moreover, our approach here of analyzing peak spectral powers and TFA measures at the 0.1-Hz frequency for the controlled breathing and comparing them with the values obtained within each frequency band during spontaneous breathing means that we effectively compared our key TFA variables without selectively missing a frequency band or being influenced by subtle band overlap. We feel that this is additionally justified, given the progressive increase in breathing frequency in the spontaneous trial. Therefore, our salient findings are unaltered, as our principal question was the influence of slow breathing on orthostatic tolerance and hence, the related comparisons with 0.1 Hz frequency for the controlled breathing intervention.
Data analysis. All data were analyzed using SPSS Statistics software (v19; IBM SPSS, Surrey, UK). The analysis of physiological responses during an incremental test to a given end-point is not straightforward, because both the end-point (presyncope) and the physiological responses leading up to the end-point may vary. Therefore, it is important to analyze all physiological responses relative to time elapsed during the orthostatic challenge (26) . Because the changes in circulatory function are inherently dependent on individual time to presyncope during an incremental test of orthostatic tolerance, we adopted the summary statistics approach for analyzing this type of time series data (2). Thus we examined the controlled breathing effect in our a priori-selected summary statistics of baseline and presyncope values, as well as the baseline presyncope rate of change over time during the orthostatic test.
Differences between supine baseline and presyncope measurements for controlled and spontaneous breathing were analyzed using paired t-tests. The only exceptions to this were the dynamic cerebrovascular response and BRS measures from the TFA, as mentioned above, where the comparison between breathing protocols was made between the final 5 min of HUT (with no LBNP) and the final, tolerated 5-min stage of combined HUT and LBNP. For all variables, individual rates of change were calculated by dividing the difference between baseline and presyncope by the time to reach presyncope. Differences in these rates of change were analyzed with paired t-tests, as were differences in time to reach presyncope and the cumulative stress index. All data are expressed as means Ϯ SD, statistical significance was set at an ␣-level of 0.05, and 95% confidence intervals (95% CI) are also presented for the primary comparison. Values are expressed as means Ϯ SD. MAP, mean arterial blood pressure (BP); SBP, systolic BP; DBP, diastolic blood pressure; TPRi, total peripheral resistance index; HR, heart rate; SV, stroke volume; Q , cardiac output; MCAv, middle cerebral artery blood flow velocity; SMCAv, systolic MCAv; DMCAv, diastolic MCAv; CVRi, cerebral vascular resistance index; PETCO2, end-tidal partial pressure of carbon dioxide; VE, ventilation; Rf, respiratory frequency; VT, calculated tidal volume (VE/Rf). *Significantly different from controlled breathing at presyncope (P Ͻ 0.05); †significantly different from controlled breathing at baseline (P Ͻ 0.05); ‡vs. controlled breathing at baseline (P ϭ 0.07). min; 95% CI: 2.9 -6.1 min; P Ͻ 0.01). Consequently, the cumulative stress index was less with spontaneous breathing (266 Ϯ 186 mmHg/min) compared with controlled breathing (471 Ϯ 244 mmHg/min; P Ͻ 0.01). All participants experienced presyncope, as defined by a drop in SBP below 80 mmHg for Ͼ10 s (number of participants: controlled breathing, six of 16; spontaneous breathing, seven of 16), the manifestation of presyncopal symptoms (number of participants: controlled breathing, 15/16; spontaneous breathing, 15/16), or both. Overall, the total presyncopal score out of 70 did not differ between the controlled (14 Ϯ 9) and spontaneous breathing (14 Ϯ 8; P ϭ 0.90). The major symptoms experienced at presyncope were described as dizziness, visual disturbances, fatigue, sweaty palms and feet, and nausea.
RESULTS
Orthostatic
Baseline cardiorespiratory and cerebrovascular responses. No difference was observed for MAP, SBP, diastolic BP, TPRi, HR, SV, and Q at baseline during either breathing protocol (P Ͼ 0.17; Table 1 ). Mean MCAv, systolic MCAv, and diastolic MCAv were significantly lower during controlled breathing; by 6 Ϯ 6 cm/s (ϳ11%), 8 Ϯ 9 cm/s (ϳ9%), and 6 Ϯ 5 cm/s (ϳ16%), respectively (all P Ͻ 0.01), which was consistent with the lower P ET CO 2 , on average, during controlled breathing (P ϭ 0.07; Table 1 and Fig. 1 ). Mean CVRi was 0.12 Ϯ 0.21 mmHg·cm Ϫ1 ·s Ϫ1 (ϳ8%) higher during controlled breathing (P ϭ 0.04). As expected, breathing frequency was lower during the controlled breathing (6 Ϯ 1 vs. 16 Ϯ 5 breaths/min, control vs. spontaneous breathing, respectively; P Ͻ 0.001), yet minute ventilation did not differ between breathing protocol (P ϭ 0.97; Table 1) .
Change over time across HUT and LBNP. In response to orthostatic stress, MAP (Fig. 1) , SBP, and diastolic BP decreased during both breathing protocols (Table 2) . Nevertheless, the mean absolute rate of change over time to presyncope was greater during spontaneous breathing compared with controlled breathing (P Յ 0.01; Table 2 ). During controlled breathing, TPRi was consistent across the orthostatic stress (P ϭ 0.57; ; P ϭ 0.03 vs. controlled breathing; Table 2} . The mean rate of change for the increase in HR and the decrease in SV and Q in response to the incremental stress did not differ between the two breathing protocols (P Ͼ 0.18; Table 2 ).
Mean MCAv (Fig. 1) , systolic MCAv, and diastolic MCAv decreased during both breathing protocols, with a significantly faster absolute rate of decline during spontaneous breathing (P Ͻ 0.01; Table 2 ). No statistical difference (P Ͼ 0.11) was observed in the absolute rate of change between controlled and spontaneous breathing for CVRi and P ET CO 2 ( Table 2 ). The absolute rate of increase for minute ventilation was 0.20 Ϯ 0.16 liter·min Ϫ1 ·min Ϫ1 faster during spontaneous breathing compared with controlled breathing (P ϭ 0.02).
Cardiorespiratory and cerebrovascular changes at orthostatic tolerance. At presyncope in the controlled breathing condition, MAP, diastolic BP, and TPRi were, respectively, 7 Ϯ 11 mmHg (P ϭ 0.03), 8 Ϯ 11 mmHg (P ϭ 0.01), and 2.7 Ϯ 4.0 mmHg·l Ϫ1 ·min Ϫ1 (P ϭ 0.02) higher compared with spontaneous breathing. SV was 6.2 Ϯ 11.0 ml lower (P ϭ 0.04), and HR was, on average, 7 Ϯ 13 beats/min higher (P ϭ 0.06) during controlled breathing. There were no statistically evident differences in SBP or Q (P Ͼ 0.13).
Mean MCAv did not differ with breathing protocol at presyncope (P ϭ 0.57; Fig. 1 ) nor did systolic MCAv, diastolic MCAv, or CVRi (P Ͼ 0.27), whereas all, except CVRi, were lower than baseline (Table 1) . Finally, at tolerance, minute ventilation was 4.8 Ϯ 6.3 l/min lower during controlled breathing (P ϭ 0.01) despite an approximate twofold-larger tidal volume, whereas P ET CO 2 was not statistically different (25.0 vs. 26.6 mmHg, controlled vs. spontaneous; P ϭ 0.13; Table 1) .
Alterations in cerebrovascular control and BRS with controlled breathing. Breathing at six breaths/min markedly increased the spectral power indices of dynamic cerebrovascular control relative to all frequency ranges assessed during spontaneous breathing, both at the HUT baseline and for the final, completed 5-min stage of combined HUT and LBNP (Table 3 and Fig. 2, A and B) . TFA revealed that the controlled breathing increased coherence, whereas the gain measure sampled at 0.1 Hz was lower relative to that within the respective fre- Fig. 1 . Mean Ϯ SD baseline changes in partial pressure of end-tidal carbon dioxide (PETCO2), middle cerebral artery blood flow velocity (MCAv), and mean arterial blood pressure [(BP) MAP] across time to presyncope (min) with controlled breathing (•) and spontaneous breathing (Ⅲ). Although PETCO2 and MCAv were different at baseline between the breathing protocols, neither was different at presyncope, whereas MAP was higher at presyncope. A significantly faster rate of decline to presyncope for MCAv and MAP was observed with spontaneous breathing. *Significantly different from controlled breathing at baseline (P Ͻ 0.05); †different from spontaneous breathing at tolerance (P Ͻ 0.05); † †different time-based change from baseline to presyncope than spontaneous breathing (P Ͻ 0.05); (*)vs. controlled breathing at baseline (P ϭ 0.07).
quency range (i.e., LF: 0.07-0.20 Hz) during spontaneous breathing for both HUT and at tolerance. Consistent with an improvement in the dynamic cerebrovascular response, phase was elevated during the controlled breathing (P Ͻ 0.05; Table 3) .
Similarly, spectral power indices of BRS were increased during controlled breathing relative to all frequency ranges assessed during spontaneous breathing for both HUT and the final, completed 5-min stage of combined HUT and LBNP (Table 4 and Fig. 2, C and D) . These changes in spectral power indices were also reflected in an elevated coherence between R-R and SBP (Table 4) .
DISCUSSION
With the use of a randomized, crossover sham-controlled study design, the main findings of this study were: 1) tolerance time to presyncope was improved with controlled, slow breathing; 2) there was a slower rate of decline for MCAv and MAP during controlled breathing across time from baseline to presyncope; and 3) the improved tolerance with controlled breathing was likely mediated via beneficial changes in, at least, cerebrovascular function (i.e., elevations in LF oscillations of mean MCAv and MAP, increased LF phase, and reduced LF gain). Collectively, these findings indicate that tolerance to orthostatic stress can be improved markedly within healthy individuals with a simple, nonpharmacological breathing strategy.
Slow, controlled breathing improves orthostatic tolerance. To the best of our knowledge, the present study is the first randomized, sham-controlled crossover design to show that "physiological traits" associated at higher orthostatic tolerance [e.g., higher endogenous oscillations of MCAv and MAP (39)] can be induced acutely within an individual by simply breathing at a rate of six breaths/min. We observed that this controlled breathing strategy (via alterations in rate and depth) improved tolerance time by an average ϳ4.5 min to our 
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Breathing Control and Orthostatic Tolerance • Lucas SJE et al. incremental combined HUT and LBNP stress test and allowed an ϳ80% greater cumulative stress index. Our findings are in accordance with a series of recent studies that illustrate the role of intrathoracic pressure and the respiratory pump in improving orthostatic tolerance when using an inspiratory resistance device (6, 40, 43) . These researchers observed greater oscillations in BP and MCAv and a reduced respiratory rate associated with the improved tolerance (40) , although this reduced respiratory rate was still outside of the reported LF range of 0.04 -0.15 Hz (was 11 breaths/min; i.e., 0.18 Hz). Furthermore, they have also illustrated that individuals with greater tolerance of LBNP stress have higher endogenous oscillations of mean MCAv and MAP compared with individuals with lower tolerance (39) . In addition, increased inspiratory resistance has been shown to improve orthostatic tolerance in autonomic-failure patients (49) . It is important to note that the implications of our findings are limited to the specific population that we tested; nevertheless, the potential for targeting disease and syncope-susceptible populations is exciting and warrants further investigation to test whether such a simple, nonpharmacological intervention can protect against recurrent syncope.
Slow breathing leads to favorable changes in cerebrovascular control. The reduction of the respiratory rate to approximately six breaths/min entrains R-R interval fluctuations, causing a merging with the respiratory cycle as well as a considerable increase in amplitude of BP oscillations in the LF (ϳ0.1 Hz; see Fig. 2) range (18, 35) . Consistent with these changes, our slow-breathing condition induced large oscilla- tions in BP, as reflected in enhanced LF power (Table 2) , and a greater respiratory sinus arrhythmia pattern (Fig. 3) . The putative mechanisms are that negative intrathoracic pressures are known to improve right-venous return and left-ventricular SV (4, 17); therefore, since TPRi remained unchanged during breathing at six breaths/min, any given increase in left-ventricular output would cause a proportional rise in MAP and therefore, contribute (depending on the effectiveness of the dynamic cerebrovascular responses to such short-duration changes in BP) to the increase in cerebral blood flow. This is consistent with the notion that slow-breathing modulation of SV causes directionally similar fluctuations in Q and MAP (51), ultimately producing spontaneous variability in cerebral blood flow (8, 58) . In addition to this increased mechanical effect of "pushing" blood into the heart (and brain) to improve perfusion during reductions in central blood volume, the generation of greater negative pressures in the thorax during the slower and deeper inspiration has been suggested to accelerate the passage of blood through tissue capillary beds via the creation of a vacuum and to reduce intracranial pressure, thus maximizing the pressure gradient and hence, perfusion pressure across the cerebral circulation (7) .
Consistent with recent findings (39, 40) , the LF oscillations in arterial BP were matched by similar LF oscillations in MCAv and appear linked to improved tolerance to reductions in central blood volume (induced by the LBNP orthostatic stress). As noted previously by Rickards and colleagues (39, 40) , traditionally, such hemodynamic instability has been linked with impaired regulation and associated with imminent syncope (10, 30) ; however, our findings lend further support to the potential protective effect that a pulsatile arterial BP and MCAv pattern may have for improving tolerance to reductions in central blood volume (27, 39, 57) . Interestingly, Rickards and colleagues (39) also report that breathing rate had a limited role in generating the higher endogenous LF oscillations in MAP and MCAv in their higher tolerance group, since breathing rates were not different from that of the lower tolerance group. However, given that the mean rates were 13-16 breaths/ min across the entire range of orthostatic stress (including baseline) for both groups, it is not surprising that respiratoryinduced R-R interval entrainment and subsequent respiratory sinus arrhythmia and BP pattern were not evident. Furthermore, given that the endogenous oscillatory pattern only became evident during the orthostatic stress (Ϫ60 mmHg and above) in this higher tolerance group, it would seem that regardless of how the oscillatory pattern is induced (endogenously, with increased respiratory resistance, or via slow breathing), this pulsatile pattern is protective against reductions in central blood volume.
Our measures of the dynamic cerebrovascular response indicated improved control of cerebral perfusion, illustrated by reduced gain of transfer function between the MAP and MCAv, and an increased phase delay between LF oscillations in BP and MCAv. Although phase changes were not reported, the changes in LF gain have been previously linked to improved orthostatic tolerance with these oscillatory patterns (39, 40) . Previous reports, however, have shown the dynamic cerebrovascular response (traditionally referred to as "dynamic cerebral autoregulation") to be maintained at presyncope (33, 44, 45) or impaired (37, 59) . Potentially, our improved dynamic cerebrovascular control observation likely reflects the stable breathing pattern that we induced throughout the stress, as reflected in the similar breathing rate at presyncope compared with baseline during the controlled breathing trial (both approximately six breaths/min; Table 1 ). Moreover, Ocon and colleagues (37) observed a biphasic change in "autoregulation," with a virtual loss of autoregulation during the faint and early recovery phases but ϳ2 min before fainting autoregulation improved. Therefore, our finding of an enhanced, dynamic cerebrovascular response during the final, completed (and steady-state) 5-min stage before presyncope with controlled breathing appears consistent with the prolonging of tolerance to orthostatic stress and taken together with the findings of Ocon et al. (37) and Rickards et al. (39) , illustrates that the oscillatory pattern and improved vascular control not only improve tolerance but likely occur as an attempt to maintain circulatory stability (i.e., avoid circulatory collapse) when syncope is imminent. Our data indicate that this pulsatile Values are means Ϯ SD. *Different from controlled breathing at HUT (P Ͻ 0.05); †different from controlled breathing at tolerance (P Ͻ 0.05).
pattern induced by controlled, slow and deep breathing can improve orthostatic tolerance, partially via favorable changes in cerebrovascular function. The mechanisms by which these oscillations improve tolerance have been suggested to be via the release of nitric oxide and inhibition of endothelin release driven by the increased endothelium shear stress induced by the oscillations (57), consequently increasing local perfusion within the cerebral tissue and particularly within the brain stem where consciousness is controlled (11, 48) . Experimental evidence to confirm or refute these findings is now required. Methodological considerations. Blood velocity in the MCA was measured by transcranial Doppler ultrasound. Previous studies have shown that MCAv is a reliable and valid index of cerebral blood flow even under orthostatic stress (14, 47) and changes in arterial PCO 2 (14) . It should be noted here that we did not measure cerebral blood flow directly to or within the brain stem but rather, within the MCA; however, such systemic oscillations in BP seem unlikely not to be translated into similar oscillations in cerebral perfusion for this region of the brain. Indeed, we have recently reported similar changes in velocity and flow in the anterior and posterior regions of the brain during marked changes in orthostatic stress (12) . Nevertheless, confirmation of this assumption seems warranted during conditions of presyncope.
We did not directly assess sympathetic activity. Given the conflicting observations in the literature (29, 35 ) and the problems associated with interpreting changes in sympathetic nerve activity via TFA, speculating what may have occurred during our experiment is problematic. Further investigations are needed to confirm the role and improve our understanding of sympathetic activity during syncope. However, it should be noted that syncope (at least in patients with autonomic disorders) is not associated explicitly with sudden sympathetic withdrawal (42) .
We also did not perform assessment of changes in intrathoracic pressure. As alluded to above, it is highly likely that the increased tolerance associated with the slower breathing fre- Fig. 3 . Representative traces of BP, MCAv, PETCO2, and heart rate for 1 participant across the final 2 min of the 15-min HUT only and in combination with Ϫ30 mmHg lower-body negative pressure (LBNP) during the spontaneous (left) and slow, controlled breathing condition (shaded; right). This participant reached presyncope ϳ10 s from the start of the next stage (Ϫ40 mmHg) during spontaneous breathing, whereas the participant completed another 2 incremental stages of LBNP before reaching presyncope during the controlled breathing condition.
quency, in part, reflected improved cerebral (and systemic tissue) circulation, resulting from the mechanical effects of lowered intrathoracic pressure associated with deeper inspiration (7) . Such measurements could have provided insight into the respiratory interactions and the cerebrovascular and hemodynamic differences observed between our two experimental conditions. Nevertheless, the twofold-larger tidal volume at presyncope that we observed during our controlled breathing trial provides some evidence for the likely occurrence of increased intrathoracic pressure from deeper breaths taken at this slow rate.
We attempted to remove perceived focus from the breathing strategy as the means of improving orthostatic tolerance to that of the tonic that we gave to participants at each trial. Every attempt was made to conceal the reality of the distilled water. Regardless, the clear differences in breathing rate and LF power between trials indicate that we were able to induce the desired physiological effect of the pulsatile BP and MCAv pattern in one condition vs. the other. Moreover, regardless of whether participants did the controlled breathing condition first or second, it improved tolerance time relative to spontaneous breathing [with only one subject with a shorter tolerance time (17 s) during controlled breathing]. However, it is difficult to rule out completely a placebo effect having some form of influence.
Perspectives. Syncope does not necessarily depend on "abnormal" physiological control. For example, the physiological responses observed in healthy humans with high orthostatic tolerance are similar to those in frequent fainters (19) ; i.e., the difference is in the amount of stress required to induce the same end-point. Furthermore, epidemiological data [e.g., refs. (32, 54, 60) ] and experimental studies (16, 26) indicate that there is a higher occurrence of vasovagal syncope in the morning, and the incidence of reflex syncope is nearly twice as common in young age groups (Ͻ40 years) as in older age groups (Ͼ60 years) (41) . The present study describes a novel and simple, as well as nonpharmacological, method to improve orthostatic tolerance. Compared with the ϳ15% improvement in orthostatic tolerance that we observed here, previous studies have reported a 10 -12% improvement in tolerance when using an inspiratory-resistance device compared with a sham device (6, 40, 43) . The use of slow and deep breathing during periods when the risk of syncope is elevated (e.g., early morning, reduced central blood volume as a consequence of hemorrhage, or following prolonged exercise) appears beneficial for, at least, healthy (but susceptible) populations.
Such regularization of breathing, with appropriate training, may also provide a meaningful adjunct to validated techniques, such as lower-body muscle tensing (20 -22) , representing a simple, nonpharmacological means capable of offsetting imminent syncope. Further research is required to examine whether this strategy will benefit disease populations with elevated risk of syncope.
